| Market Cap | 622M 537M 504M 460M 865M 59.36B 869M 5.97B 2.33B 30.02B 2.34B 2.29B 99.62B | P/E 2027 * |
-9.1x | P/E 2028 * | -21.3x |
|---|---|---|---|---|---|
| Enterprise Value | 596M 514M 482M 440M 828M 56.8B 832M 5.71B 2.23B 28.73B 2.24B 2.19B 95.33B | EV / Sales 2027 * |
0.53x | EV / Sales 2028 * | 0.5x |
| Free-Float |
98.49% | Yield 2027 * |
-
| Yield 2028 * | - |
Last Transcript : Aphria Inc
| 1 day | -3.50% |
| Manager | Title | Age | Since |
|---|---|---|---|
Irwin Simon
CEO | Chief Executive Officer | 67 | 2021-04-30 |
Carl Merton
DFI | Director of Finance/CFO | 57 | 2021-04-30 |
Roger Savell
ADM | Chief Administrative Officer | 64 | 2022-03-30 |
| Director | Title | Age | Since |
|---|---|---|---|
Irwin Simon
CHM | Chairman | 67 | 2021-04-30 |
David Clanachan
BRD | Director/Board Member | 64 | 2021-04-29 |
John Herhalt
BRD | Director/Board Member | 69 | 2021-04-30 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -3.50% | -1.94% | - | - | 620M | ||
| -0.13% | -5.61% | +59.99% | +112.16% | 1,048B | ||
| +0.85% | +0.25% | +51.61% | +61.23% | 640B | ||
| -1.03% | -2.43% | +22.79% | +74.16% | 456B | ||
| -1.46% | -3.52% | +36.60% | +38.39% | 362B | ||
| -0.72% | -2.06% | +21.34% | +37.92% | 295B | ||
| -1.19% | -0.98% | +0.79% | +12.29% | 255B | ||
| -1.05% | -0.30% | +50.16% | +68.66% | 236B | ||
| +0.08% | -0.22% | -17.16% | -53.76% | 204B | ||
| -2.14% | +1.56% | +27.88% | +89.54% | 185B | ||
| Average | -0.98% | -0.72% | +28.22% | +48.95% | 409.07B | |
| Weighted average by Cap. | -0.45% | -1.92% | +37.92% | +65.36% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | 1.12B 969M 909M 830M 1.56B 107B 1.57B 10.77B 4.2B 54.15B 4.22B 4.12B 180B | 1.18B 1.02B 952M 869M 1.64B 112B 1.64B 11.29B 4.41B 56.75B 4.42B 4.32B 188B |
| Net income | -61.49M -53.09M -49.76M -45.43M -85.48M -5.86B -85.89M -590M -230M -2.97B -231M -226M -9.84B | -26.86M -23.19M -21.74M -19.85M -37.35M -2.56B -37.52M -258M -101M -1.3B -101M -98.66M -4.3B |
| Net Debt | -26.8M -23.13M -21.69M -19.8M -37.25M -2.56B -37.43M -257M -100M -1.29B -101M -98.41M -4.29B | -39.31M -33.93M -31.81M -29.04M -54.64M -3.75B -54.9M -377M -147M -1.9B -148M -144M -6.29B |
Employees
-
Sector
Pharmaceuticals
















